These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15253056)

  • 21. Further epidemiological investigations on subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1980; 31(3):173-82. PubMed ID: 6254241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
    Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subacute sclerosing panencephalitis in Italy. An epidemiological study.
    Cianchetti C; Ferrante P; Marrosu MG
    Acta Neurol Scand; 1986 Feb; 73(2):160-7. PubMed ID: 3705924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia.
    Khetsuriani N; Sanadze K; Abuladze M; Tatishvili N
    Clin Microbiol Infect; 2020 Jun; 26(6):737-742. PubMed ID: 31707133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Data on the incidence of subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1978; 29(3):177-82. PubMed ID: 695322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of subacute sclerosing panencephalitis in Japan.
    Abe Y; Hashimoto K; Iinuma K; Ohtsuka Y; Ichiyama T; Kusuhara K; Nomura K; Mizuguchi M; Aiba H; Suzuki Y; Mizusawa H; Hosoya M
    J Child Neurol; 2012 Dec; 27(12):1529-33. PubMed ID: 22408143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
    Naruszewicz-Lesiuk D; Iwińska-Buksowicz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Neurol Neurochir Pol; 2000; 34(5):877-85. PubMed ID: 11253477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation.
    Schönberger K; Ludwig MS; Wildner M; Weissbrich B
    PLoS One; 2013; 8(7):e68909. PubMed ID: 23874807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute sclerosing panencephalitis in The Netherlands--1976-1990.
    Beersma MF; Galama JM; Van Druten HA; Renier WO; Lucas CJ; Kapsenberg JG
    Int J Epidemiol; 1992 Jun; 21(3):583-8. PubMed ID: 1634322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subacute sclerosing panencephalitis (SSPE) in Poland in the years 1993-1995. The sixth stage of epidemiological research].
    Naruszewicz-Lesiuk D; Iwińska-Buksowioz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Przegl Epidemiol; 1997; 51(4):371-80. PubMed ID: 9562784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epilepsy in children with subacute sclerosing panencephalitis.
    Jović NJ
    Srp Arh Celok Lek; 2013; 141(7-8):434-40. PubMed ID: 24073547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subacute sclerosing panencephalitis cases diagnosed by increased CSF/serum measles antibody indices].
    Samlıoğlu P; Unalp A; Gökçay A; Altuğlu I; Oztürk A; Zeytinoğlu A
    Mikrobiyol Bul; 2012 Oct; 46(4):716-8. PubMed ID: 23188587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progressive cognitive disturbances in a 17-year-old boy].
    Hepp DH; van Dijk K; Stam CJ; van Oosten BW; Foncke EM
    Ned Tijdschr Geneeskd; 2015; 159():A8490. PubMed ID: 25761293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors in subacute sclerosing panencephalitis: a case-control study.
    Halsey NA; Modlin JF; Jabbour JT; Dubey L; Eddins DL; Ludwig DD
    Am J Epidemiol; 1980 Apr; 111(4):415-24. PubMed ID: 7377184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.
    Campbell C; Levin S; Humphreys P; Walop W; Brannan R
    BMC Pediatr; 2005 Dec; 5():47. PubMed ID: 16356180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.